Rahul Kakkar - Net Worth and Insider Trading
Rahul Kakkar Net Worth
The estimated net worth of Rahul Kakkar is at least $43 Million dollars as of 2025-04-12. Rahul Kakkar is the CEO of Pandion Therapeutics Inc and owns about 716,515 shares of Pandion Therapeutics Inc (PAND) stock worth over $43 Million. Details can be seen in Rahul Kakkar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Rahul Kakkar has not made any transactions after 2020-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Rahul Kakkar
Rahul Kakkar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Rahul Kakkar owns 1 companies in total, including Pandion Therapeutics Inc (PAND) .
Click here to see the complete history of Rahul Kakkar’s form 4 insider trades.
Insider Ownership Summary of Rahul Kakkar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | director & Chief Executive Officer |
Rahul Kakkar Latest Holdings Summary
Rahul Kakkar currently owns a total of 1 stock. Rahul Kakkar owns 716,515 shares of Pandion Therapeutics Inc (PAND) as of July 21, 2020, with a value of $43 Million.
Latest Holdings of Rahul Kakkar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PAND | Pandion Therapeutics Inc | 2020-07-21 | 716,515 | 60.05 | 43,026,726 |
Holding Weightings of Rahul Kakkar
Rahul Kakkar Form 4 Trading Tracker
According to the SEC Form 4 filings, Rahul Kakkar has made a total of 1 transactions in Pandion Therapeutics Inc (PAND) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Pandion Therapeutics Inc is the acquisition of 14,000 shares on July 21, 2020, which cost Rahul Kakkar around $252,000.
Insider Trading History of Rahul Kakkar
- 1
Rahul Kakkar Trading Performance
GuruFocus tracks the stock performance after each of Rahul Kakkar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Rahul Kakkar is -38.63%. GuruFocus also compares Rahul Kakkar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Rahul Kakkar within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Rahul Kakkar's insider trading performs compared to the benchmark.
Performance of Rahul Kakkar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.94 |  | | | | |
| Relative Return to S&P 500(%) | -3.35 | | | | | |
Rahul Kakkar Ownership Network
Ownership Network List of Rahul Kakkar
Ownership Network Relation of Rahul Kakkar
Rahul Kakkar Owned Company Details
What does Pandion Therapeutics Inc do?
Who are the key executives at Pandion Therapeutics Inc?
Rahul Kakkar is the director & Chief Executive Officer of Pandion Therapeutics Inc. Other key executives at Pandion Therapeutics Inc include director & 10 percent owner Daniel J. Becker , 10 percent owner Boxer Capital, Llc , and 10 percent owner Versant Vantage I Gp-gp, Llc .
Pandion Therapeutics Inc (PAND) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Pandion Therapeutics Inc (PAND) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pandion Therapeutics Inc (PAND) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Pandion Therapeutics Inc (PAND)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pandion Therapeutics Inc Insider Transactions
Rahul Kakkar Mailing Address
Above is the net worth, insider trading, and ownership report for Rahul Kakkar. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Rahul Kakkar's mailing address is: 2nd Floor Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
